Margaret S. Wu
Merck & Co., Inc., Rahway, NJ, USA (United States) · 77 works · 11,514 citations · h-index 36
Top works
- Role of AMP-activated protein kinase in mechanism of metformin action
- Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity
- Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. studies with paf-receptor antagonist kadsurenone
- Targeted Disruption of the Tumor Necrosis Factor-α Gene: Metabolic Consequences in Obese and Nonobese Mice
- Peroxisome Proliferator-Activated Receptors γ and α Mediate in Vivo Regulation of Uncoupling Protein (UCP-1, UCP-2, UCP-3) Gene Expression
- Novel Peroxisome Proliferator-activated Receptor (PPAR) γ and PPARδ Ligands Produce Distinct Biological Effects
- Down-regulation of the Expression of the Obese Gene by an Antidiabetic Thiazolidinedione in Zucker Diabetic Fatty Rats and db/db Mice
- Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase–1
- Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase–1
- Role of Skeletal Muscle in Thiazolidinedione Insulin Sensitizer (PPARγ Agonist) Action
- Targeting a ceramide double bond improves insulin resistance and hepatic steatosis
- Incidence of premature birth and neonatal respiratory disease in infants of HIV-positive mothers
- Stimulation by Immune Complexes of Mucus Release from Goblet Cells of the Rat Small Intestine
- PPARα Agonists Reduce 11β-Hydroxysteroid Dehydrogenase Type 1 in the Liver
- Intestinal Uptake of Macromolecules
- Potentiation of Insulin Signaling in Tissues of Zucker Obese Rats After Acute and Long-Term Treatment With PPARγ Agonists
- Platelet activating factor intravenous infusion in rats stimulates vascular lysosomal hydrolase secretion independent of blood neutrophils
- FGF21 Analogs of Sustained Action Enabled by Orthogonal Biosynthesis Demonstrate Enhanced Antidiabetic Pharmacology in Rodents
- Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes
- (±)- Trans -2-(3-methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist